g-Cyclodextrin

CAS:
Other names: GCD
SMILES:

Properties

MW HBA HBD LogP TPSA Rot. Comp. Fsp3C Brutto formula
None None None None None

Availability

Suppliers Supplier IDs Storage Storage ID Quantity Class Added
CY-3001 None Jan. 1, 2023

Bar codes

Plate barcode Sample barcode

PAINS

Identified PAINS

Supramolecules

Namelog KSDpHT(°C)MethodRef
[g-Cyclodextrin](1).[Fluorescein] 1.54 Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy Flamigni, Lucia 1993
[g-Cyclodextrin](1).[Fluorescein] 2.30 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Erythrosine B] 2.04 Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy Flamigni, Lucia 1993
[g-Cyclodextrin](1).[Rose bengal] 2.00 Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy Flamigni, Lucia 1993
[g-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 2.89 7.2 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[g-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 2.89 7.5 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[g-Cyclodextrin].[phenol] 1.60 0.78 25.0 near-infrared spectrometry Tran, Chieu D. 2002
[g-Cyclodextrin].[7-methoxycoumarin] 1.61 0.90 fluorescence suppression Wagner, Brian D. 2003
[g-Cyclodextrin](1).[1-b-D ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide] 3.07 4.6 18.0 HPLC Kedzierewicz, F. 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.52 4.60 4.5 25.0 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.65 4.70 5.5 25.0 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.74 4.70 7.4 25.0 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.72 4.70 9.5 25.0 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.76 4.78 7.4 20.2 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.74 4.70 7.4 25.1 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.71 4.70 7.4 30.1 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[gymnemic acid] 5.71 4.60 7.4 35.1 isothermal titration calorimetry Oda, Masayuki 2005
[g-Cyclodextrin](1).[L-tryptophan] 1.95 0.07 7.2 25.0 Calorimetry Yu Liu 1998
[g-Cyclodextrin](1).[L-tryptophan] 2.29 1.34 8.0 18.0 UV-vis spectroscopy Andrzej Temeriusz 2006
[g-Cyclodextrin](1).[Disodium 2,7-naphthalenedisulfonate] 2.58 0.02 7.2 25.0 Calorimetry Yu Liu 1998
[g-Cyclodextrin](1).[Costa-type complex (R=n-C6H13)] 2.80 25.0 1H-NMR Hui-Lan Chen 2003
[g-Cyclodextrin](1).[Ebselen] 2.00 7.0 25.0 phase solubility Kaneto Uekama 2002
[g-Cyclodextrin](1).[Cyproterone acetate] 3.82 25.0 phase solubility Sandrine Henry De Hassonville 2002
[g-Cyclodextrin](2).[Cyproterone acetate] 1.08 25.0 phase solubility Sandrine Henry De Hassonville 2002
[g-Cyclodextrin](1).[N-(1-adamantylmethyl)-] 2.81 1.70 7.0 25.0 surface plasmon resonance (SPR) Susan E. Brown 2003
[g-Cyclodextrin](1).[N-octyl-] 2.30 7.0 25.0 surface plasmon resonance (SPR) Susan E. Brown 2003
[g-Cyclodextrin](1).[N-(4-tert-butyl benzyl)-] 2.30 7.0 25.0 surface plasmon resonance (SPR) Susan E. Brown 2003
[g-Cyclodextrin](1).[N-(1-pyrenyl methyl)-] 2.30 7.0 25.0 surface plasmon resonance (SPR) Susan E. Brown 2003
[g-Cyclodextrin](1).[Di-tert-butyl nitroxide ] 2.43 25.0 ESR Yoshimi Sueishi 1991
[g-Cyclodextrin](1).[2,3-naphthalimide] 1.78 7.0 25.0 UV and fluorescence spectroscopy Mario J. Politi 1997
[g-Cyclodextrin](1).[2,3-N-butylnaphthalimide] 2.41 7.0 25.0 UV and fluorescence spectroscopy Mario J. Politi 1997
[g-Cyclodextrin](1).[1,8-naphthalimide] 1.78 7.0 25.0 UV and fluorescence spectroscopy Mario J. Politi 1997
[g-Cyclodextrin](1).[1,8-N-butylnaphthalimide] 1.85 7.0 25.0 UV and fluorescence spectroscopy Mario J. Politi 1997
[g-Cyclodextrin](1).[spironolactone] 4.00 phase solubility Kaneto Uekama 1997
[g-Cyclodextrin](1).[spironolactone] 3.68 2.0 25.0 HPLC-method Valentino J. Stella 2000
[g-Cyclodextrin](1).[glycyrrhetinic acid] 1.20 0.38 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[g-Cyclodextrin](1).[Parsol MCX] 3.17 2.34 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.33 1.98 steady-state fluorescence measurement Francisco Mendicuti 1999
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.41 2.30 5.0 steady-state fluorescence spectroscopy Wayne L. Mattice 1998
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.43 2.28 15.0 steady-state fluorescence spectroscopy Wayne L. Mattice 1998
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.32 2.00 25.0 steady-state fluorescence spectroscopy Wayne L. Mattice 1998
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.20 1.95 35.0 steady-state fluorescence spectroscopy Wayne L. Mattice 1998
[g-Cyclodextrin](1).[2-methylnaphthoate] 2.23 1.78 45.0 steady-state fluorescence spectroscopy Wayne L. Mattice 1998
[g-Cyclodextrin](1).[Sodium fusidate] 4.78 4.38 1H and 13C NMR Wajih Al-Soufi 2003
[g-Cyclodextrin](1).[Potassium helvolate] 4.34 3.95 1H and 13C NMR Wajih Al-Soufi 2003
[g-Cyclodextrin](1).[propranolol] 1.94 1.48 7.0 25.0 Calorimetry Giuseppina Castronuovo 2006
[g-Cyclodextrin](1).[propranolol] 1.89 0.90 1.3 25.0 Calorimetry Giuseppina Castronuovo 2006
[g-Cyclodextrin](1).[2-Acetylnaphthalene] 2.03 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Adamantanecarboxylic acid] 4.38 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Adamantanecarboxylic acid anion] 3.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Adiphenine] 2.61 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[4-Aminonaphthalene-1-sulfonate anion] 1.31 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Anilinonaphthalene-8-sulfonate anion] 2.45 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Anthracene] 3.18 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Beclomethasone dipropionate] 3.80 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Bencyclane] 3.60 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Benz[a]anthracene] 2.78 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Benzene] 0.96 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Benzophenone] 2.23 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Benzo[a]pyrene] 4.81 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Benzoyltrifluoroacetone] 2.20 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Betamethasone] 4.33 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Betamethasone] 3.50 2.30 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Betamethasone 17-valerate] 3.99 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Bromazepam] 1.49 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Bromazepam] 1.49 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Bromcresol Green anion] 3.49 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Bromobenzene] 1.59 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Bromodiphenhydramine] 3.39 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Chlorcyclizine] 3.11 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Chlordiazepoxide] 2.15 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Chlordiazepoxide] 2.15 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Chlorobenzene] 1.52 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cinnarizine] 1.89 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Clobazam] 1.56 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Clonazepam] 1.76 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Congo Red] 4.24 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cortisone] 3.34 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cortisone acetate] 3.39 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[o-Cresolphthalein] 2.18 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Crystal Violet] 2.67 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Crystal Violet] 3.77 6.0 25.0 Fluorescence spectroscopy Yu Liu 2002
[g-Cyclodextrin](1).[Cyclizine] 2.86 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cyclodecane] 3.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cycloheptane] 1.20 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cyclohexane] 1.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cyclooctane] 1.85 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Cyclopentane] 0.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Daunorubicin] 2.51 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Dexamethasone] 4.42 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Dexamethasone] 3.56 2.30 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Dexamethasone acetate] 4.57 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diazepam] 2.08 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diazepam] 2.08 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[1,4-Dibromobenzene] 1.68 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Di-t-butyl nitroxide] 2.45 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,4-Dichlorobenzene] 1.63 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diethylethylphosphonate] 1.45 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diflunisal anion] 4.74 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,4-Difluorobenzene] 1.45 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,3-Dihydroxybenzene] 1.33 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,4-Diiodobenzene] 1.91 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,4-Dimethylnaphthalene] 1.00 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,5-Dimethylnaphthalene] 3.00 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,8-Dimethylnaphthalene] 2.23 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diphenidol] 2.57 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diphenylhydantoin] 2.17 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Diphenylpyraline] 2.89 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Dodecylsulfate anion] 2.92 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Doxorubicin] 2.87 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Doxorubicin anion] 2.83 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Ellipticine] 4.01 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Emetine] 2.92 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Ethylbenzene] 1.56 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Ferrocenemonocarboxylic acid anion] 2.34 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Fludiazepam] 2.28 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Fludiazepam] 2.28 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Flunitrazepam] 1.60 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Fluocinolone acetonide] 4.50 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Fluorene] 2.25 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Fluorobenzene] 1.15 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Flurazepam] 2.11 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Flurbiprofen] 2.66 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Flurbiprofen anion] 3.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Heptane] 1.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Hexane] 1.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Hydrocortisone] 3.35 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Hydrocortisone acetate] 3.36 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Hydrocortisone butyrate] 3.46 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Hydroxyzine] 3.12 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Iodobenzene] 1.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Isopropylbenzene] 1.97 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Khellin] 1.41 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Lorazepam] 2.15 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Meclizine] 2.93 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Medazepam] 2.20 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Medazepam] 2.20 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Menadione] 2.00 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Methylnaphthalene] 2.11 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2-Methylnaphthalene] 2.18 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Methyl Orange] 2.00 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Methyl Orange anion] 1.65 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Mitomycin C] 2.50 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Naphthacene] 3.23 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Naphthalene] 2.11 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2,7-Naphthalenedisulfonate] 2.58 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2-Naphthalenesulfonate anion] 1.58 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2-Naphthol] 1.72 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[a-Naphtholphthalein] 3.11 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2-Naphthoyltrifluoroacetone] 3.12 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Nimetazepam] 1.58 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Nitrazepam] 1.52 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[4-Nitrophenol] 1.79 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[4-Nitrophenol anion] 2.08 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[3-Nitrophenyl acetate] 1.48 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[4-Nitrophenyl acetate] 1.94 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[S-Nitroso-N-acetylpenicillamine] 1.59 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Nocloprost] 2.79 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Nonane] 2.00 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Octane] 1.79 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Octanol] 3.23 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1-Octanol] 1.83 0.60 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[Orphenadrine] 2.98 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Oxazepam] 1.65 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Pentane] 0.78 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Perfluoro-n-butyric acid anion] 1.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Perfluoro-n-heptanoic acid anion] 2.62 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Perfluoro-n-nonanoic acid anion] 3.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Perfluoro-n-octanoic acid anion] 2.88 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Phenanthrene] 2.89 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Phenolphthalein] 3.27 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Phloridzin] 2.61 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Prednisolone] 3.51 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Prednisolone] 2.99 1.78 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Prednisolone acetate] 3.59 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Prednisolone acetate] 3.14 1.78 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Proadifen] 3.05 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Progesterone] 4.38 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[n-Propylbenzene] 1.72 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Pyrene] 2.40 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Rhodamine B] 1.85 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Testosterone] 4.22 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Tetrabromophenolphthalein] 3.78 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Tetradecyltrimethylammonium] 3.36 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Toluene] 1.30 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[2-Toluidinylnaphthalene-6-sulfonate anion] 2.04 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Triamcinolone] 3.59 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Triamcinolone acetonide] 4.42 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Triamcinolone diacetate] 4.08 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,2,3-Trimethylbenzene] 2.46 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,2,4-Trimethylbenzene] 1.72 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[1,3,5-Trimethylbenzene] 1.38 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[Tropaeolin anion] 2.62 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[o-Xylene] 1.53 25.0 Kenneth A. Connors 1995
[g-Cyclodextrin](1).[{(+)-(3S,4R)-3-ethyl-4-[(1-methyl.5-imidazolyl)-metyl]-tetrahydrofuran-2-on}] 1.95 0.04 7.0 25.0 Potentiometry Lajos Barcza 2006
[g-Cyclodextrin](1).[chiral N-imidazole derivative 1 (R enantiomer)] 1.35 29.0 NMR spectroscopy Claude Vaccher 2006
[g-Cyclodextrin](1).[chiral N-imidazole derivative 1 (S enantiomer)] 1.12 30.0 NMR spectroscopy Claude Vaccher 2006
[g-Cyclodextrin](2).[azulene] 5.65 4.93 7.0 25.0 Absorption and fluorescence spectroscopy, induced-cirular dicroism spectroscopy Osama K. Abou-Zied 2005
[g-Cyclodextrin](1).[phenylbutazone] 3.28 2.60 7.5 25.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.15 2.48 7.5 30.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.04 2.48 7.5 37.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.85 2.95 15.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.57 2.78 20.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.56 2.70 25.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.60 3.00 30.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[phenylbutazone] 3.39 1.00 37.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[oxyphenbutazone] 3.04 1.30 15.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[oxyphenbutazone] 2.38 1.48 20.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[oxyphenbutazone] 2.51 1.60 25.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[oxyphenbutazone] 2.69 1.95 30.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[oxyphenbutazone] 2.70 2.00 37.0 UV-vis spectroscopy David Diaz 1998
[g-Cyclodextrin](1).[20(S)-Camptothecin] 1.86 1.7 25.0 HPLC-method Vijay Kumar 2002
[g-Cyclodextrin](1).[Bis( 2-pyridylcarbinolato)copper(II)] 6.26 7.0 ESR spectroscopy Hiroshi Yokoi 1991
[g-Cyclodextrin](1).[Ro 28-2653] 2.54 7.0 37.0 HPLC-method Bertholet Pascal 2005
[g-Cyclodextrin](1).[pyrene] 1.30 7.0 25.0 Fluorescence spectroscopy Takehlko Yorozu 1982
[g-Cyclodextrin](0.5).[pyrene] 6.70 7.0 25.0 Fluorescence spectroscopy Takehlko Yorozu 1982
[g-Cyclodextrin](2).[pyrene] 2.30 7.0 25.0 Fluorescence spectroscopy Takehlko Yorozu 1982
[g-Cyclodextrin](1).[2-naphthalenesul fonate] 1.58 0.03 7.2 25.0 Calorimetry Yoshihisa Inoue 1993
[g-Cyclodextrin](2).[2-naphthalenesul fonate] 2.59 0.07 7.2 25.0 Calorimetry Yoshihisa Inoue 1993
[g-Cyclodextrin](1).[2,7-naphthalenedisulfonate ] 2.58 0.02 7.2 25.0 Calorimetry Yoshihisa Inoue 1993
[g-Cyclodextrin](1).[4-amino-1-naphthalenesulfonate] 1.31 0.08 7.2 25.0 Calorimetry Yoshihisa Inoue 1993
[g-Cyclodextrin](1).[risperidone] 2.16 10.5 25.0 UV-Vis spectroscopy M.B. Zughul 2005
[g-Cyclodextrin](1).[9-methylanthracene] 3.23 2.48 25.0 Fluorescence spectroscopy Vincent C. Reinsborough 1995
[g-Cyclodextrin](2).[manganese(III) tetrakis(4-sulfonatopheny1)porphine] 1.61 7.0 25.0 UV-vis spectroscopy Robert G. Bryant 1995
[g-Cyclodextrin](1).[2-[ (p-amino)phenyl]-3,3-dimethyl-5-cyano-3H-indole] 3.09 9.5 25.0 Fluorescence spectroscopy Gilles Durocher 1997
[g-Cyclodextrin](2).[2-[ (p-amino)phenyl]-3,3-dimethyl-5-cyano-3H-indole] 1.20 9.5 25.0 Fluorescence spectroscopy Gilles Durocher 1997
[g-Cyclodextrin](1).[2-[ (p-dimethylamino)phenyll-3,3-dimethyl-5-cyano-3H-indole] 3.89 9.5 25.0 Fluorescence spectroscopy Gilles Durocher 1997
[g-Cyclodextrin](2).[2-[ (p-dimethylamino)phenyll-3,3-dimethyl-5-cyano-3H-indole] 1.60 9.5 25.0 Fluorescence spectroscopy Gilles Durocher 1997
[g-Cyclodextrin](1).[12-crown-4] 1.04 7.6 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[12-crown-4] 1.32 2.0 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[12-crown-4] 1.49 14.0 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[12-crown-4] 1.00 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[cyclen] 1.28 7.6 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[1,4,7,10-tetrathiacyclododecane] 1.32 25.0 NMR diffusion measurements Yoram Cohen 1997
[g-Cyclodextrin](1).[glisentide] 2.16 0.90 4.2 15.0 UV-vis spectroscopy A. Zornoza 1998
[g-Cyclodextrin](1).[glisentide] 1.99 0.70 4.2 25.0 UV-vis spectroscopy A. Zornoza 1998
[g-Cyclodextrin](1).[glisentide] 1.93 0.60 4.2 30.0 UV-vis spectroscopy A. Zornoza 1998
[g-Cyclodextrin](1).[glisentide] 1.82 0.48 4.2 37.0 UV-vis spectroscopy A. Zornoza 1998
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] 3.41 2.34 7.0 25.0 NMR spectroscopy M. Cotta Ramusino 1998
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] 3.23 2.26 7.0 25.0 UV-vis spectroscopy M. Cotta Ramusino 1998
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] 3.20 2.48 7.0 25.0 Circular dichroism spectroscopy M. Cotta Ramusino 1998
[g-Cyclodextrin](1).[chlorpromazine hydrochloride] 2.62 7.4 37.0 Surface tension Noriaki Funasaki 1999
[g-Cyclodextrin](1).[chlorpromazine hydrochloride] 3.00 25.0 UV-vis spectroscopy Noriaki Funasaki 1999
[g-Cyclodextrin](1).[propantheline bromide] 2.36 37.0 Surface tension Noriaki Funasaki 1999
[g-Cyclodextrin](0.5).[propantheline bromide] 1.85 37.0 Surface tension Noriaki Funasaki 1999
[g-Cyclodextrin](1).[indomethacin] 2.43 1.60 10.0 40.0 HPLC-method Thorsteinn Loftsson 1999
[g-Cyclodextrin](1).[chlorambucil] 2.54 1.00 7.5 30.0 HPLC-method Thorsteinn Loftsson 1999
[g-Cyclodextrin](1).[chlorambucil] 3.49 2.69 4.15 37.0 UV spectroscopy Yannis L. Loukas 1997
[g-Cyclodextrin](1).[Benzyl tert-butyl nitroxide] 1.71 7.0 21.0 EPR spectroscopy Marco Lucarini 2004
[g-Cyclodextrin](1).[benzo-15-crown-5 ether derivative] 1.78 7.0 25.0 Fluorescence spectroscopy Norio Teramae 2000
[g-Cyclodextrin](0.5).[benzo-15-crown-5 ether derivative] 5.82 7.0 25.0 Fluorescence spectroscopy Norio Teramae 2000
[g-Cyclodextrin](2).[benzo-15-crown-5 ether derivative] 2.53 7.0 25.0 Fluorescence spectroscopy Norio Teramae 2000
[g-Cyclodextrin](1).[dibenzyl nitroxide] 1.83 7.0 21.0 EPR spectroscopy Marco Lucarini 2004
[g-Cyclodextrin](1).[di-tert amyl nitroxide] 2.41 7.0 21.0 EPR spectroscopy Marco Lucarini 2004
[g-Cyclodextrin](1).[Fe(III)-tetrakis(sulfonatophenyl)porphyrin] 0.64 0.08 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[g-Cyclodextrin](1).[pancreatic a-amylase] 2.54 6.9 30.0 UV-vis spectroscopy Roger Koukiekolo 2001
[g-Cyclodextrin](1).[tetrakis(sulfonatophenyl)porphyrin] 0.87 0.02 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[g-Cyclodextrin](1).[Pb(II) nitrate] 2.89 1.03 Cyclic voltammetry Maria Teresa Ramirez-Silva 2005
[g-Cyclodextrin](1).[eugenol] 5.17 7.0 20.0 UV-vis spectroscopy Le Xin Song 2005
[g-Cyclodextrin](1).[diflunisal] 4.74 3.30 7.0 25.0 UV-vis spectroscopy John H. Coates 1988
[g-Cyclodextrin](2).[diflunisal] 4.36 3.30 7.0 25.0 NMR spectroscopy John H. Coates 1988
[g-Cyclodextrin](1).[Rocuronium Bromide] 4.26 3.30 30.0 NMR spectroscopy Lee Fielding 2002
[g-Cyclodextrin](1).[NADH] 0.37 6.0 25.0 HPLC-method Manabu Seno 1990
[g-Cyclodextrin](1).[NADP] 0.49 6.0 25.0 HPLC-method Manabu Seno 1990
[g-Cyclodextrin](1).[Gd-1] 4.97 7.0 25.0 Proton Relaxation Enhancement Method Silvio Aime 2006
[g-Cyclodextrin](1).[(S)-(+)-6-methoxy-a-methyl-2-naphthaleneacetic acid] 2.58 0.05 2.5 20.0 Fluorescence spectroscopy Graciela M. Escandar 2001
[g-Cyclodextrin](1).[(S)-(+)-6-methoxy-a-methyl-2-naphthaleneacetic acid] 2.47 0.07 10.0 20.0 Fluorescence spectroscopy Graciela M. Escandar 2001
[g-Cyclodextrin](1).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 2.36 1.48 Fluorescence spectroscopy Athena Kasselouri 1999
[g-Cyclodextrin](2).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 4.38 3.08 Fluorescence spectroscopy Athena Kasselouri 1999
[g-Cyclodextrin](1).[Nitrazepam ] 1.52 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Nimetazepam ] 1.58 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Flunitrazepam ] 1.60 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](2).[Flunitrazepam ] 0.30 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Pindolol] 1.58 0.85 12.0 25.0 HPLC-method Arantza Zornoza 2005
[g-Cyclodextrin](1).[Clonazepam ] 1.76 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Flurazepam ] 2.11 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Lorazepam ] 2.15 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[oxazepam ] 1.65 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[Clobazam ] 1.56 7.0 25.0 UV-vis spectroscopy M. Otagiri 1983
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] 2.99 7.0 15.0 UV-vis spectroscopy Kaneto Uekama 1990
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] 2.79 7.0 25.0 UV-vis spectroscopy Kaneto Uekama 1990
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] 2.64 7.0 35.0 UV-vis spectroscopy Kaneto Uekama 1990
[g-Cyclodextrin](1).[2-dibenzofuran carboxylate] 2.78 2.30 10.0 27.0 NMR spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](0.5).[2-dibenzofuran carboxylate] 3.85 3.30 10.0 27.0 NMR spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[doxorubicin] 2.81 1.5 25.0 HPLC-method W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.30 1.5 50.0 HPLC-method W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.78 1.5 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.51 1.5 50.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.78 3.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.46 3.0 50.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.83 7.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.79 10.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[doxorubicin] 2.85 10.0 25.0 UV-vis spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.69 1.5 25.0 HPLC-method W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.32 1.5 50.0 HPLC-method W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.75 1.5 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.60 1.5 50.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.73 3.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.59 3.0 50.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.89 7.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.76 10.0 25.0 Circular dichroism spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[daunorubicin] 2.81 10.0 25.0 UV-vis spectroscopy W. J. M. Underberg 1990
[g-Cyclodextrin](1).[hydrocortisone butyrate ] 3.52 4.0 20.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[g-Cyclodextrin](1).[hydrocortisone butyrate ] 3.41 4.0 30.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[g-Cyclodextrin](1).[hydrocortisone butyrate ] 3.32 4.0 37.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[g-Cyclodextrin](1).[hydrocortisone butyrate ] 3.31 4.0 25.0 Circular dichroism spectroscopy In Koo Chun 1993
[g-Cyclodextrin](1).[hydrocortisone butyrate ] 3.17 4.0 25.0 UV-vis spectroscopy In Koo Chun 1993
[g-Cyclodextrin](1).[sodium decanoate] 1.48 0.85 7.0 20.0 NMR spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[Diphenidol HCl] 2.57 1.02 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Orphenadrine HCI ] 2.98 2.06 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Bromodiphenhydramine HCl ] 3.39 1.70 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Diphenylpyraline HCI ] 2.89 1.29 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Cyclizine HCl] 2.86 1.26 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Chlorcyclizine HCI] 3.11 1.71 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Chlorcyclizine 2HCl] 3.04 1.56 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Meclizine 2HCl] 2.93 1.07 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Hydroxyzine HCI] 3.08 1.78 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Hydroxyzine 2HCl ] 3.12 1.96 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Proadifen HCl] 3.05 1.70 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Adiphenine HCl ] 2.61 0.88 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[Cinnarizine 2HCl] 1.89 0.26 7.0 25.0 Calorimetry Bradley D. Anderson 1993
[g-Cyclodextrin](1).[fenoprofen calcium dihydrate] 1.72 0.29 7.4 25.0 UV-vis spectroscopy David Diaz 1999
[g-Cyclodextrin](1).[fenoprofen calcium dihydrate] 1.80 -0.29 7.4 25.0 Fluorescence spectroscopy David Diaz 1999
[g-Cyclodextrin](1).[tryptophan] 1.08 0.78 7.0 30.0 NMR spectroscopy Akira Harada 2006
[g-Cyclodextrin](1).[phenylalanine] 0.48 7.0 30.0 NMR spectroscopy Akira Harada 2006
[g-Cyclodextrin](1).[poly(N-methacryloyltryptophan)] 1.30 0.30 7.0 25.0 Fluorescence spectroscopy Akira Harada 2006
[g-Cyclodextrin](1).[poly(N-methacryloyltryptophan)] 1.04 0.30 7.0 30.0 NMR spectroscopy Akira Harada 2006
[g-Cyclodextrin](1).[lanthanide (III) chelates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonate] 1.20 0.30 7.0 25.0 Isothermal calorimetry Margarida Bastos 2003
[g-Cyclodextrin](1).[lanthanide (III) chelates of 1,4,7,10-tertraazacyclododecane-1,4,7,10-tetraacetate] 1.00 0.30 7.0 25.0 Isothermal calorimetry Margarida Bastos 2003
[g-Cyclodextrin](1).[R-18-T5] 1.71 0.48 George W. Gokel 2003
[g-Cyclodextrin](1).[S-18-T5] 1.61 George W. Gokel 2003
[g-Cyclodextrin](1).[(P)-1,12-dimethylbenzo[c]phenantrene-5,8-dicarboxylic acid] 3.49 2.00 7.0 25.0 NMR spectroscopy George W. Gokel 2003
[g-Cyclodextrin](1).[(M)-1,12-dimethylbenzo[c]phenantrene-5,8-dicarboxylic acid] 2.84 1.30 7.0 25.0 NMR spectroscopy George W. Gokel 2003
[g-Cyclodextrin](2).[2-anthracenecarboxylate] 6.90 5.36 9.1 25.0 HPLC method Hiroshi Ikeda 2005
[g-Cyclodextrin](1).[p-Xylene] 1.53 25.0 Toshio Shinbo 2004
[g-Cyclodextrin](1).[butyric acid] 0.52 0.04 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[valeric acid] 1.13 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[isovaleric acid] 1.33 0.53 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[succinic acid] 0.82 0.51 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[succinic acid] 0.41 -0.22 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[cadaverine] 1.05 0.36 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[putrescine] 1.18 0.23 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[pyridine ] 1.28 0.26 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[3-methyl-pyridine] 1.46 0.51 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[diphenylamine] 1.76 0.89 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[hydrogen sulfide] 0.70 -0.08 22.0 HS-GCMS Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[methanethiol] 0.40 -1.00 22.0 HS-GCMS Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[dimethyl sulfide] 0.92 -0.35 22.0 HS-GCMS Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[phenyl acetate] 1.15 0.20 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[m-cresol] 1.99 0.91 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[phenol ] 0.41 0.15 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[indole] 1.32 0.30 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[skatole] 1.47 0.46 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[dodecanol] 1.91 1.16 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[tatradecanol] 1.93 1.16 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[ampicillin] 1.28 0.60 7.0 25.0 NMR spectroscopy Konstantina Yannakopoulou 2006
[g-Cyclodextrin](1).[dicloxacillin] 2.79 2.30 7.0 25.0 NMR spectroscopy Konstantina Yannakopoulou 2006
[g-Cyclodextrin](1).[styrene] 2.57 Kasi Pitchumani 2005
[g-Cyclodextrin](1).[methyl cinnamate] 2.45 Kasi Pitchumani 2005
[g-Cyclodextrin](1).[phenylacetylene] 2.48 Kasi Pitchumani 2005
[g-Cyclodextrin](1).[allylbenzene] 2.51 Kasi Pitchumani 2005
[g-Cyclodextrin](1).[cyclosporin A] 1.82 7.0 25.0 HPLC method Laura Matilainen 2006
[g-Cyclodextrin](1).[salicylidine-3,4,7-methyl amine] 2.38 7.0 23.0 Fluorescence spectroscopy S. Mukherjee 2005
[g-Cyclodextrin](1).[b-lapachone] 2.20 0.70 7.4 25.0 UV-vis spectroscopy Jinming Gao 2003
[g-Cyclodextrin](1).[1-{[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl}-4-methylpiperazine] 1.66 1.28 8.7 30.0 UV-vis spectroscopy Mahmoud M. Al Omari 2006
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] 4.08 3.00 2.0 25.0 Fluorescence spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] 2.70 1.78 10.0 15.0 Fluorescence spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] 2.65 1.78 10.0 25.0 Fluorescence spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] 2.60 1.78 10.0 35.0 Fluorescence spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] 2.48 2.00 10.0 45.0 Fluorescence spectroscopy Gustavo González-Gaitano 2004
[g-Cyclodextrin](0.5).[4-CH3O-Phenol] 4.15 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](0.5).[Phenol] 4.08 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](0.5).[4-Br-Phenol] 5.20 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](0.5).[4-NO2-Phenol] 5.40 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](0.5).[4-CH3-Phenol] 6.34 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](0.5).[4-I-Phenol] 6.43 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](1).[4-(CH3)2CH-Phenol] 3.23 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](1).[1-Naphthol] 2.79 6.9 40.0 UV-vis spectroscopy Yoshimi Sueishi 2003
[g-Cyclodextrin](1).[a-ethyl-2,4,6-trimethoxybenzyl tertbutyl nitroxide ] 1.92 7.0 25.0 Electron Paramagnetic Resonance Yoshimi Sueishi 2004
[g-Cyclodextrin](1).[ketoconazole] 2.93 1.48 6.0 25.0 UV-vis spectroscopy Joanna Taraszewska 2005
[g-Cyclodextrin](1).[naftifine] 2.26 1.20 12.0 25.0 UV-vis spectroscopy Itziar Velaz 2006
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 6.30 5.63 7.4 5.0 Ion selective electrode potentiometry P.E. Macheras 1999
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 5.79 5.10 7.4 15.0 Ion selective electrode potentiometry P.E. Macheras 1999
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 4.95 3.97 7.4 25.0 Ion selective electrode potentiometry P.E. Macheras 1999
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 4.77 4.21 7.4 37.0 Ion selective electrode potentiometry P.E. Macheras 1999
[g-Cyclodextrin](1).[2,3-diazabicyclo[2.2.2]oct-2-ene] 0.78 0.48 7.0 25.0 NMR spectroscopy Werner M. Nau 1999
[g-Cyclodextrin](1).[Tb-podate] 5.30 7.3 20.0 Luminescence titrations Jean-Claude G. Bünzli 2000
[g-Cyclodextrin](1).[beclomethasone] 2.85 HPLC-method Nicholas H. Snow 2001
[g-Cyclodextrin](1).[betamethasone] 2.23 HPLC-method Nicholas H. Snow 2001
[g-Cyclodextrin](1).[dexamethasone] 3.01 HPLC-method Nicholas H. Snow 2001
[g-Cyclodextrin](1).[D9,11-betamethasone] 3.00 HPLC-method Nicholas H. Snow 2001
[g-Cyclodextrin](1).[α-asarone] 3.31 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[ferulic acid] 2.85 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[magnolol] 3.07 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[honokiol] 2.93 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[acridine red] 2.07 6.0 25.0 Fluorescence spectroscopy Yu Liu 2002
[g-Cyclodextrin](1).[sodium 6-p-toluidino-2-naphthalenesulfonic acid] 2.25 6.0 25.0 Fluorescence spectroscopy Yu Liu 2002
[g-Cyclodextrin](1).[cinchonidine] 2.51 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[cinchonine] 2.66 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[quinine] 2.34 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[quinidine] 2.31 7.2 25.0 Fluorescence spectroscopy Yu Liu 2003
[g-Cyclodextrin](1).[atrazine] 4.28 7.0 Polarography L. Pospisil 1998
[g-Cyclodextrin](1).[Naphtalene-1-sulfonate] 1.51 0.69 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-1-sulfonate] 1.45 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-2-sulfonate] 1.60 0.83 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-2-sulfonate] 1.52 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-1,5-disulfonate] 1.47 0.54 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-1,5-disulfonate] 1.38 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[dansyl-branched saccharide cyclophane] 2.88 7.0 25.0 Fluorescence spectroscopy Osamu Hayashida 2002
[g-Cyclodextrin](1).[Naphtalene-1,6-disulfonate] 1.49 0.62 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-1,6-disulfonate] 1.37 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-2,6-disulfonate] 1.59 0.62 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[Naphtalene-2,6-disulfonate] 1.51 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[N-carboxybenzoyl-D-glutamyl-L-tyrosine] 1.99 0.30 6.9 25.0 Isothermal titration calorimetry Yoshihisa Inoue 2004
[g-Cyclodextrin](1).[N-carboxybenzoyl-L-glutamyl-L-tyrosine] 1.60 0.30 6.9 25.0 Isothermal titration calorimetry Yoshihisa Inoue 2004
[g-Cyclodextrin](1).[3-aminonaphtalene-2,7-disulfonate] 1.56 0.78 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[3-aminonaphtalene-2,7-disulfonate] 1.37 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[5,10,15-tris(3,5-dicarboxylatophenyl)-20-phenylporphyrin] 2.81 1.48 7.0 25.0 Isothermal titration calorimetry Koji Kano 2005
[g-Cyclodextrin](1).[(S)-20,30,50-trimethyl-40-hydroxy-a-dodecylthio-phenylacetanilide] 1.30 7.0 25.0 Fluorescence spectroscopy Philippe Morin 2005
[g-Cyclodextrin](1).[2-aminonaphtalene-1,5-disulfonate] 1.24 0.76 3.0 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[2-aminonaphtalene-1,5-disulfonate] 1.13 9.2 25.0 Capillary electrophoresis Wang-Hsien Ding 2004
[g-Cyclodextrin](1).[rocuronium bromide] 6.11 5.48 7.0 10.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](1).[rocuronium bromide] 6.15 5.30 7.0 25.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](1).[rocuronium bromide] 6.04 5.48 7.0 32.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](1).[rocuronium bromide] 5.95 5.30 7.0 35.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](1).[rocuronium bromide] 5.54 4.48 7.0 40.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](0.5).[rocuronium bromide] 3.60 3.18 7.0 10.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](0.5).[rocuronium bromide] 3.30 2.70 7.0 25.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](0.5).[rocuronium bromide] 3.18 2.48 7.0 32.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](0.5).[rocuronium bromide] 3.11 2.23 7.0 35.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](0.5).[rocuronium bromide] 2.85 2.00 7.0 40.0 Isothermal titration microcalorimetry Ronald Palin 2005
[g-Cyclodextrin](1).[triclosan] 1.30 7.0 25.0 UV-vis spectroscopy P. Mura 2005
[g-Cyclodextrin](1).[2-dibenzofuranol] -0.48 -2.05 7.0 15.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](1).[2-dibenzofuranol] -0.41 -1.70 7.0 25.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](1).[2-dibenzofuranol] -0.51 -1.70 7.0 35.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](1).[2-dibenzofuranol] -0.62 -2.22 7.0 45.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](0.5).[2-dibenzofuranol] 1.45 -0.30 7.0 15.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](0.5).[2-dibenzofuranol] 1.12 -0.52 7.0 25.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](0.5).[2-dibenzofuranol] 0.87 -0.70 7.0 35.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](0.5).[2-dibenzofuranol] 1.05 -1.00 7.0 45.0 Fluorescence spectroscopy Gustavo Gonzalez-Gaitano 2005
[g-Cyclodextrin](1).[[(−)-(5R,6S)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol]] 3.19 0.03 7.0 25.0 Potentiometry Lajos Barcza 2006
[g-Cyclodextrin](1).[sodium-2-naphthalenesulfonate] 2.63 23.0 NIR spectroscopy Chieu D. Tran 1995
[g-Cyclodextrin](1).[sodium-1-pyrenesulfonate] 2.00 23.0 NIR spectroscopy Chieu D. Tran 1995
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] 3.17 35.0 HPLC Ekaterini Antoniadou-Vyza 1994
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] 3.10 40.0 HPLC Ekaterini Antoniadou-Vyza 1994
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] 2.94 45.0 HPLC Ekaterini Antoniadou-Vyza 1994
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] 2.85 50.0 HPLC Ekaterini Antoniadou-Vyza 1994
[g-Cyclodextrin](1).[Estradiol] 3.85 2.60 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Ethinyloestradiol] 4.03 2.98 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Estriol] 3.51 2.57 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Estrone] 3.41 2.36 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Nandrolone] 3.36 1.90 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Norethisterone] 3.72 2.36 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Methylprednisolone] 3.00 1.90 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Methylprednisolone acetate] 3.12 1.90 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Betamethasone phosphate] 3.18 2.54 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[Dexamethasone phosphate] 3.30 2.70 35.0 HPLC Nina Sadlej-Sosnowska 1997
[g-Cyclodextrin](1).[methyl tert-butyl ether] 2.56 25.0 GC Ji-Won Yang 2003
[g-Cyclodextrin](1).[n-hexane] 0.46 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](2).[praziquantel] 1.18 30.0 UV spectroscopy Gordon Becket 1999
[g-Cyclodextrin](1).[n-heptane] 1.49 1.26 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[n-octane] 1.23 0.78 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[n-nonane] 0.88 0.63 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[n-decane] 1.30 1.26 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[n-dodecane] 1.56 1.34 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[Me-cyclohexane] 0.95 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[Et-cyclohexane] 0.90 0.30 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[benzene] 0.94 0.94 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[1-Butanol] 0.30 -1.00 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[toluene] 1.52 0.78 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[o-xylene] 1.76 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[m-xylene] 1.26 1.08 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[p-xylene] 1.51 1.36 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[Et-benzene] 2.10 1.46 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[1,3,5-trimethyl-benzene] 1.26 0.48 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[1,2,3-trimethyl-benzene] 2.24 1.48 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[1,2,4-trimethyl-benzene] 0.93 0.59 25.0 GC (SHSGC) É. Fenyvesi 2005
[g-Cyclodextrin](1).[1-Pentanol] 0.52 -0.40 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[2-Pentanol] 0.49 -1.00 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[1-Hexanol] 1.11 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[1-Heptanol] 1.57 0.48 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[1-Nonanol] 2.15 0.30 25.0 GC Isao Sanemasa 1999
[g-Cyclodextrin](1).[phenolphthalein] 3.31 2.15 10.5 25.0 UV/VIS spectroscopy Bruno Szpoganicz 2001
[g-Cyclodextrin](1).[decanoate ] 2.40 1.70 10.5 25.0 UV/VIS spectroscopy Bruno Szpoganicz 2001
[g-Cyclodextrin](1).[octanoate] 1.67 0.30 10.5 25.0 UV/VIS spectroscopy Bruno Szpoganicz 2001
[g-Cyclodextrin](1).[tetradecyltrimethylammonium bromide] 2.75 1.63 25.0 Potentiometric titration Toshihiro Tominaga 1994
[g-Cyclodextrin](0.5).[tetradecyltrimethylammonium bromide] 3.75 2.99 25.0 Potentiometric titration Toshihiro Tominaga 1994
[g-Cyclodextrin](1).[4,4’-bipyridine] 1.65 25.0 stopped-flow spectrophotometry R.Prado-Gotor 2006
[g-Cyclodextrin](1).[norflurazon] 1.57 0.23 25.0 HPLC, fluorescence spectroscopy Jaime Villaverde 2005
[g-Cyclodextrin](1).[2-anthracenecarboxylic acid] 2.26 20.0 UV-vis, NMR and circular dichroism spectroscopy Yoshihisa Inoue 2006
[g-Cyclodextrin](1).[2-anthracenecarboxylic acid] 2.26 20.0 circular dichroism spectroscopy Yoshihisa Inoue 2006
[g-Cyclodextrin](0.5).[2-anthracenecarboxylic acid] 4.75 20.0 UV-vis, NMR and circular dichroism spectroscopy Yoshihisa Inoue 2006
[g-Cyclodextrin](0.5).[2-anthracenecarboxylic acid] 4.75 20.0 circular dichroism spectroscopy Yoshihisa Inoue 2006
[g-Cyclodextrin](1).[adamantane carboxylate] 3.00 10.0 25.0 UV-vis spectroscopy Rita H. de Rossi 1995
[g-Cyclodextrin](1).[sodium perfluorooctanoate] 2.81 10.0 25.0 UV-vis spectroscopy Rita H. de Rossi 1995
[g-Cyclodextrin](1).[2-(2’-hydroxyphenyl)benzimidazole] 1.65 7.0 25.0 fluorescence spectroscopy Isiah M.Warner 1996
[g-Cyclodextrin](1).[2-(2¢-hydroxyphenyl)benzoxazole] 2.15 7.0 25.0 fluorescence spectroscopy Isiah M.Warner 1996
[g-Cyclodextrin](1).[2-(2’-hydroxyphenyl)benzothiazole] 2.21 7.0 25.0 fluorescence spectroscopy Isiah M.Warner 1996
[g-Cyclodextrin](1).[2-(2’-methoxyphenyl)benzothiazole] 2.40 7.0 25.0 fluorescence spectroscopy Isiah M.Warner 1996
[g-Cyclodextrin](1).[calcichrome] 2.63 2.15 25.0 NMR spectroscopy Bo-Long Poh 1996
[g-Cyclodextrin](1).[tert-butyl group on polymer chain] 1.76 NMR spectroscopy Akira Harada 1997
[g-Cyclodextrin](1).[isooctyl group on polymer chain] 1.71 NMR spectroscopy Akira Harada 1997
[g-Cyclodextrin](1).[dodecyl group on polymer chain] 2.39 NMR spectroscopy Akira Harada 1997
[g-Cyclodextrin](1).[riboflavin 5'-(dihydrogen phosphate) monosodium salt] 3.45 2.52 fluorescence spectroscopy Yannis L. Loukas 1997
[g-Cyclodextrin](1).[warfarin] 2.28 9.5 25.0 fluorescence spectroscopy Mamoru Kamiya 1997
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] 2.11 0.45 11.6 25.0 spectrofluorometry Oswald S.Tee 1996
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] 3.10 25.0 NMR titration Oswald S.Tee 1996
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] 2.44 25.0 fluorescence spectroscopy Oswald S.Tee 1996
[g-Cyclodextrin](1).[prednisolone] 3.25 1.68 5.5 25.0 NMR spectroscopy Kim L.Larsen 2005
[g-Cyclodextrin](1).[prednisolone] 3.51 25.0 NMR, UV-vis spectroscopy, X-ray diffraction Kim L.Larsen 2005
[g-Cyclodextrin](1).[6a-methyl prednisolone] 3.40 1.98 5.5 25.0 NMR spectroscopy Kim L.Larsen 2005
[g-Cyclodextrin](1).[malic acid] 0.23 -0.52 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[tartaric acid] 0.28 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[maleic acid] 0.32 -0.52 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[citric acid] 0.40 0.04 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[iodid ion] 0.86 0.23 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[perchlorate ion (ClO4-)] 0.73 0.15 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[fulminate ion (CNO-)] 1.68 0.83 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[thiocianate/rodanid ion (SCN-)] 0.79 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[dichromate ion(Cr2O72-)] 1.26 0.46 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[L-phenylalanine] 0.18 -0.52 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[L-tryptophane] 1.17 0.04 freezing point depression method, osmotic measurements Masahiko Suzuki 1993
[g-Cyclodextrin](1).[benzoate ion] 0.48 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[2-methyl benzoate ion] 0.85 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[3-methyl benzoate ion] 0.78 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[4-methyl benzoate ion] 0.90 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[2,4-dimethyl benzoate ion] 0.90 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[2,5-dimethyl benzoate ion] 0.78 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[3,5-dimethyl benzoate ion] 0.85 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[3,5-dimethoxy benzoate ion] 1.00 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[salicylate ion] 1.11 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[3-phenyl propionate ion] 0.85 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[4-tert-butyl benzoate ion] 1.87 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[ibuprofen anion] 1.83 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] 1.62 25.0 capillary electrophoresis Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] 3.48 25.0 microcalorimetry Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] 2.43 0.95 25.0 spectrophotometry Wolfgang Zimmermann 1998
[g-Cyclodextrin](1).[palmoic acid] 3.61 2.85 10.8 25.0 fluorescence spectroscopy, circular dichroism Koji Kano 1991
[g-Cyclodextrin](1).[2,2'-dihydroxy-1,1'-dinaphthylmethane] 2.32 1.48 5.5 25.0 fluorescence spectroscopy, circular dichroism Koji Kano 1991
[g-Cyclodextrin](1).[3-hydroxy-2-naphthoic acid] 2.10 1.00 5.5 25.0 fluorescence spectroscopy, circular dichroism Koji Kano 1991
[g-Cyclodextrin](0.5).[gentian violet] 7.90 7.30 7.5 25.0 UV-vis spectroscopy David Díaz 1999
[g-Cyclodextrin](1).[gentian violet] 1.03 -0.40 25.0 UV-vis spectroscopy David Díaz 1999
[g-Cyclodextrin](1).[1-adamantanol] 4.41 6.4 20.0 electrochemical masurements, cyclic voltammetry Marcin Majda 2000
[g-Cyclodextrin](1).[1-adamantane carboxylate] 3.48 25.0 pH titration Marcin Majda 2000
[g-Cyclodextrin](1).[nabumetone] 3.46 2.60 15.0 fluorescence spectroscopy Nathir A.F. Al-Rawashdeh 2005
[g-Cyclodextrin](1).[nabumetone] 3.34 2.00 25.0 fluorescence spectroscopy Nathir A.F. Al-Rawashdeh 2005
[g-Cyclodextrin](1).[nabumetone] 3.23 2.00 35.0 fluorescence spectroscopy Nathir A.F. Al-Rawashdeh 2005
[g-Cyclodextrin](1).[nabumetone] 3.08 2.00 45.0 fluorescence spectroscopy Nathir A.F. Al-Rawashdeh 2005
[g-Cyclodextrin](1).[adamantanecarboxylate] 3.52 8.5 25.0 microcalorimetry, pH potentiometry Maurice R. Eftink 1985
[g-Cyclodextrin](1).[adamantanecarboxylate] 3.52 4.08 25.0 microcalorimetry, pH potentiometry Maurice R. Eftink 1985
[g-Cyclodextrin](1).[adamantanecarboxylate] 3.38 4.5 25.0 microcalorimetry, pH potentiometry Maurice R. Eftink 1985
[g-Cyclodextrin](1).[adamantanecarboxylic acid] 2.70 7.22 25.0 microcalorimetry, pH potentiometry Maurice R. Eftink 1985
[g-Cyclodextrin](1).[adamantanecarboxylic acid] 4.38 4.08 25.0 microcalorimetry, pH potentiometry Maurice R. Eftink 1985
Comment